NEW ADVANCES IN SEVERE ADVERSE DRUG RESCTIONS
- 1 October 2001
- journal article
- Published by Elsevier in Dermatologic Clinics
- Vol. 19 (4) , 697-709
- https://doi.org/10.1016/s0733-8635(05)70309-0
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- A Role for Bioactivation and Covalent Binding within Epidermal Keratinocytes in Sulfonamide-Induced Cutaneous Drug ReactionsJournal of Investigative Dermatology, 2000
- Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivityPublished by Elsevier ,2000
- Nitric Oxide Synthase in Toxic Epidermal Necrolysis and Stevens–Johnson SyndromeJournal of Investigative Dermatology, 2000
- Elevated serum levels of interleukins 5, 6, and 10 in a patient with drug-induced exanthem caused by systemic corticosteroidsJournal of the American Academy of Dermatology, 1998
- Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: Case report and review of drug-induced Sweet's syndromeJournal of the American Academy of Dermatology, 1996
- Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retnoic acid therapyPublished by Elsevier ,1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virusJournal of the American Academy of Dermatology, 1992
- Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.Journal of Clinical Investigation, 1988
- Pretreatment with Corticosteroids to Alleviate Reactions to Intravenous Contrast MaterialNew England Journal of Medicine, 1987